Answers are grounded in this paper and cite their sources.
The search for new anti-cancer drugs from natural products is one of the most prominent research areas of treatment of cancer. Honey finds a vital role in various applications using its anti-inflammatory, antioxidant, antibacterial and antitumor properties. We investigated the potential of honey to induce cytotoxic and antiproliferative effects in cultured human prostate cancer cell line (PC-3) in comparison to non-malignant (L929) cells. Both cells were cultured in RPMI medium and treated with the selected crude honey sample at various concentrations (5, 10 and 15%) for three consecutive days. The results revealed that the cell viability decreased in a concentration and time- dependent manner in the malignant cells treated with honey in comparison with non-malignant cells. Honey showed anti-proliferative activity with the IC50 value 4, 10 and 14% after 24, 48 and 72 h, respectively in PC-3 cell line. Overall, it can be concluded that higher concentrations of honey is safe for L929, but it exerts anti-tumor cytotoxicity and anti-proliferative effects in a prostate cancer-derived cell line. Thus, it is considered as a potential chemotherapeutic agent against prostate cancer.
No takes yet. Share an insight, caveat, or question.
Saeed et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: